Skip to content

Fedra Fallahian, MD

NPI 1821583618ActiveIndividual· Surgery, Surgical Oncology· Houston, TX

Surgery, Surgical Oncology (MD) in Houston, Texas, trained at University of Missouri, Kansas City, School of Medicine (class of 2018). Part D covered 46 prescriptions written in 2024, 100% of them generic. Abbvie Inc. was the largest of 2 companies reporting payments in 2025, $281.41 in all, mostly food and beverage.

Overview

NPI1821583618
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedJun 25, 2018
Last updated in NPPESSep 4, 2024
Certified by providerSep 4, 2024

Specialties and licenses

TaxonomyCodeLicenseState
Surgery, Surgical Oncology Primary2086X0206XU3836TX
Surgery208600000X2018022088MO

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Surgical Oncology (TX)

Part D prescriptions in 2024

Prescriptions (claims)46 · 46 30-day fills
Patients26
Total drug cost$161.22
Generic share100% of claims

Medicare sources and data years

Education and affiliations

Medical schoolUniversity of Missouri, Kansas City, School of Medicine
Graduation year2018
Medicare specialtySurgical Oncology

Medical group

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$281.41 · 2 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Abbvie Inc.$149.711
Endomagnetics Ltd$131.701

What the 2025 payments were for

  • Food and Beverage$281.41 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Surgery, Surgical Oncology providers in Houston

All Surgery, Surgical Oncology providers in Texas →